Annual SGA
$15.72 M
-$3.99 M-20.24%
December 1, 2024
Summary
- As of March 11, 2025, NXTC annual SGA is $15.72 million, with the most recent change of -$3.99 million (-20.24%) on December 1, 2024.
- During the last 3 years, NXTC annual SGA has fallen by -$4.86 million (-23.60%).
- NXTC annual SGA is now -27.60% below its all-time high of $21.71 million, reached on December 31, 2022.
Performance
NXTC SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.55 M
-$172.00 K-4.62%
December 1, 2024
Summary
- As of March 11, 2025, NXTC quarterly SGA is $3.55 million, with the most recent change of -$172.00 thousand (-4.62%) on December 1, 2024.
- Over the past year, NXTC quarterly SGA has stayed the same.
- NXTC quarterly SGA is now -40.85% below its all-time high of $6.01 million, reached on June 30, 2021.
Performance
NXTC Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.45 B
-$55.65 M-4.00%
December 1, 2024
Summary
- As of March 11, 2025, NXTC TTM SGA is -$1.45 billion, with the most recent change of -$55.65 million (-4.00%) on December 1, 2024.
- Over the past year, NXTC TTM SGA has dropped by -$1.46 billion (-9307.60%).
- NXTC TTM SGA is now -2959.92% below its all-time high of -$47.30 million.
Performance
NXTC TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NXTC Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.2% | 0.0% | -9307.6% |
| 3 y3 years | -23.6% | 0.0% | -9307.6% |
| 5 y5 years | +63.5% | 0.0% | -9307.6% |
NXTC Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.6% | at low | -38.2% | at low | -124.9% | at low |
| 5 y | 5-year | -27.6% | +63.5% | -40.9% | +35.7% | -443.5% | at low |
| alltime | all time | -27.6% | +505.7% | -40.9% | +344.7% | -2959.9% | at low |
NextCure Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $15.72 M(-20.2%) | $3.55 M(-4.6%) | $15.72 M(-2.5%) |
| Sep 2024 | - | $3.73 M(-8.6%) | $16.13 M(-5.2%) |
| Jun 2024 | - | $4.08 M(-6.6%) | $17.01 M(-8.8%) |
| Mar 2024 | - | $4.36 M(+10.1%) | $18.65 M(-5.4%) |
| Dec 2023 | $19.71 M(-9.2%) | $3.96 M(-14.0%) | $19.71 M(-4.8%) |
| Sep 2023 | - | $4.61 M(-19.3%) | $20.69 M(-5.1%) |
| Jun 2023 | - | $5.71 M(+5.3%) | $21.80 M(+1.9%) |
| Mar 2023 | - | $5.42 M(+9.6%) | $21.39 M(-1.5%) |
| Dec 2022 | $21.71 M(+5.5%) | $4.95 M(-13.3%) | $21.71 M(+0.7%) |
| Sep 2022 | - | $5.71 M(+7.7%) | $21.57 M(+3.9%) |
| Jun 2022 | - | $5.30 M(-7.7%) | $20.77 M(-3.3%) |
| Mar 2022 | - | $5.75 M(+19.6%) | $21.47 M(+4.4%) |
| Dec 2021 | $20.57 M | $4.81 M(-2.1%) | $20.57 M(+3.4%) |
| Sep 2021 | - | $4.91 M(-18.2%) | $19.90 M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $6.01 M(+23.9%) | $19.64 M(+7.3%) |
| Mar 2021 | - | $4.85 M(+17.4%) | $18.31 M(+7.4%) |
| Dec 2020 | $17.05 M(+77.4%) | $4.13 M(-11.3%) | $17.05 M(+9.7%) |
| Sep 2020 | - | $4.66 M(-0.3%) | $15.54 M(+15.1%) |
| Jun 2020 | - | $4.67 M(+30.2%) | $13.50 M(+17.0%) |
| Mar 2020 | - | $3.59 M(+37.1%) | $11.54 M(+20.1%) |
| Dec 2019 | $9.61 M(+182.0%) | $2.62 M(-0.2%) | $9.61 M(+23.0%) |
| Sep 2019 | - | $2.62 M(-3.4%) | $7.81 M(+27.7%) |
| Jun 2019 | - | $2.71 M(+63.6%) | $6.12 M(+43.3%) |
| Mar 2019 | - | $1.66 M(+102.6%) | $4.27 M(+25.2%) |
| Dec 2018 | $3.41 M(+31.4%) | $819.00 K(-11.5%) | $3.41 M(+31.6%) |
| Sep 2018 | - | $925.00 K(+6.8%) | $2.59 M(+55.6%) |
| Jun 2018 | - | $866.00 K(+8.4%) | $1.67 M(+108.4%) |
| Mar 2018 | - | $799.00 K | $799.00 K |
| Dec 2017 | $2.60 M | - | - |
FAQ
- What is NextCure annual SGA?
- What is the all time high annual SGA for NextCure?
- What is NextCure annual SGA year-on-year change?
- What is NextCure quarterly SGA?
- What is the all time high quarterly SGA for NextCure?
- What is NextCure quarterly SGA year-on-year change?
- What is NextCure TTM SGA?
- What is the all time high TTM SGA for NextCure?
- What is NextCure TTM SGA year-on-year change?
What is NextCure annual SGA?
The current annual SGA of NXTC is $15.72 M
What is the all time high annual SGA for NextCure?
NextCure all-time high annual SGA is $21.71 M
What is NextCure annual SGA year-on-year change?
Over the past year, NXTC annual SGA has changed by -$3.99 M (-20.24%)
What is NextCure quarterly SGA?
The current quarterly SGA of NXTC is $3.55 M
What is the all time high quarterly SGA for NextCure?
NextCure all-time high quarterly SGA is $6.01 M
What is NextCure quarterly SGA year-on-year change?
Over the past year, NXTC quarterly SGA has changed by $0.00 (0.00%)
What is NextCure TTM SGA?
The current TTM SGA of NXTC is -$1.45 B
What is the all time high TTM SGA for NextCure?
NextCure all-time high TTM SGA is -$47.30 M
What is NextCure TTM SGA year-on-year change?
Over the past year, NXTC TTM SGA has changed by -$1.46 B (-9307.60%)